Tuomi, T. et al. The many faces of diabetes: A disease with increasing heterogeneity. Lancet 383, 1084–1094. https://doi.org/10.1016/S0140-6736(13)62219-9 (2014).
Tuomi, T. et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48, 150–157 (1999).
Zinman, B. et al. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53, 3193–3200 (2004).
Hawa, M. I. et al. Metabolic syndrome and autoimmune diabetes: Action LADA 3. Diabetes Care 32, 160–164 (2009).
Andersen, M. K. et al. Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 33, 2062–2064 (2010).
Zhou, Z. et al. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China Study): A nationwide, multicenter, clinic-based cross-sectional study. Diabetes 62, 543–550 (2013).
Mishra, R. et al. Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. BMC Med 15, 1 (2017).
Cousminer, D. L. et al. First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes. in Diabetes Care vol. 41 2396–2403 (American Diabetes Association Inc., 2018).
Andersen, M. K. et al. Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes. Diabetologia 57, 1859–1868 (2014).
Ramu, D., Perumal, V. & Paul, S. F. D. Association of common type 1 and type 2 diabetes gene variants with latent autoimmune diabetes in adults: A meta-analysis. J. Diabetes 11, 484–496 (2019).
Andersen, M. K. New insights into the genetics of latent autoimmune diabetes in adults. Curr. Diabetes Rep. https://doi.org/10.1007/s11892-020-01330-y (2020).
Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).
Vujkovic-Cvijin, I. et al. Host variables confound gut microbiota studies of human disease. Nature. 587, 448–454 (2020).
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science. 307, 1915–1920. https://doi.org/10.1126/science.1104816 (2005).
Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 1979(312), 1355–1359 (2006).
Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. https://doi.org/10.1038/s41579-020-0433-9 (2020).
Tai, N., Wong, F. S. & Wen, L. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev. Endocr. Metab. Disord. 16, 55–65. https://doi.org/10.1007/s11154-015-9309-0 (2015).
Durazzo, M., Ferro, A. & Gruden, G. Gastrointestinal microbiota and type 1 diabetes mellitus: The state of art. J. Clin Med. 8, 1843 (2019).
Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. https://doi.org/10.1016/j.ebiom.2019.11.051 (2020).
Watts, T. et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc. Natl. Acad. Sci. USA 102, 2916–2921 (2005).
Bosi, E. et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 49, 2824–2827 (2006).
Musso, G., Gambino, R. & Cassader, M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu. Rev. Med. 62, 361–380 (2011).
Fang, Y. et al. Characteristics of the gut microbiota and metabolism in patients with latent autoimmune diabetes in adults: A case-control study. Diabetes Care 44, 2738–2746 (2021).
Hu, J. et al. Distinct signatures of gut microbiota and metabolites in different types of diabetes: A population-based cross-sectional study. EClinicalMedicine. 62, 102132 (2023).
Shkoporov, A. N. et al. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe 26, 527-541.e5 (2019).
Zhao, G. et al. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc. Natl. Acad. Sci. USA 114, E6166–E6175 (2017).
Ma, Y., You, X., Mai, G., Tokuyasu, T. & Liu, C. A human gut phage catalog correlates the gut phageome with type 2 diabetes. Microbiome 6, 1–12 (2018).
Li, J. et al. Actinomyces and alimentary tract diseases: A review of its biological functions and pathology. BioMed. Res. Int. https://doi.org/10.1155/2018/3820215 (2018).
Liu, H. et al. Alterations of gut microbiota and blood lipidome in gestational diabetes mellitus with hyperlipidemia. Front. Physiol. 10, 1015 (2019).
Del Chierico, F. et al. Gut Microbiota markers in obese adolescent and adult patients: Age-dependent differential patterns. Front. Microbiol. 9, 1210 (2018).
Zhang, X. et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8, e71108 (2013).
Leiva-Gea, I. et al. Gut microbiota differs in composition and functionality between children with type 1 diabetes and MODY2 and healthy control subjects: A case-control study. Diabetes Care 41, 2385–2395 (2018).
Allin, K. H. et al. Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia 61, 810–820 (2018).
Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013).
Babukumar, S., Vinothkumar, V., Sankaranarayanan, C. & Srinivasan, S. Geraniol, a natural monoterpene, ameliorates hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Pharm. Biol. 55, 1442–1449 (2017).
Rhee, E. J. & Plutzky, J. Retinoid metabolism and diabetes mellitus. Diabetes Metab. J. 36, 167–180. https://doi.org/10.4093/dmj.2012.36.3.167 (2012).
Roohbakhsh, A., Karimi, G. & Iranshahi, M. Carotenoids in the treatment of diabetes mellitus and its complications: A mechanistic review. Biomed. Pharmacother. 91, 31–42. https://doi.org/10.1016/j.biopha.2017.04.057 (2017).
Thingholm, L. B. et al. Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe 26, 252-264.e10 (2019).
Siljander, H., Honkanen, J. & Knip, M. Microbiome and type 1 diabetes. EBioMedicine. 46, 512–521. https://doi.org/10.1016/j.ebiom.2019.06.031 (2019).
Tong, X. et al. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional chinese herbal formula: A multicenter, randomized, open label clinical trial. mBio 9, 2392–2409 (2018).
Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850–858 (2017).
Fitzgerald, C. B. et al. Probing the “dark matter” of the human gut phageome: culture assisted metagenomics enables rapid discovery and host-linking for novel bacteriophages. Front. Cell Infect. Microbiol. 11, 100 (2021).
Garmaeva, S. et al. Stability of the human gut virome and effect of gluten-free diet. Cell Rep. 35, 109132 (2021).
Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447–460 (2015).
Tomofuji, Y. et al. Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease. Ann. Rheum. Dis. 81, 278–288 (2022).
Yang, K. et al. Alterations in the gut virome in obesity and type 2 diabetes mellitus. Gastroenterology 161, 1257-1269.e13 (2021).
Chen, Q. et al. Enteric phageome alterations in patients with type 2 diabetes. Front. Cell Infect. Microbiol. 10, 856 (2021).
Alvarez-Silva, C. et al. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India. Genome Med. 13, 1–13 (2021).
Dantoft, T. M. et al. Cohort description: The Danish study of Functional Disorders. Clin. Epidemiol. 9, 127–139 (2017).
Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
Vandeputte, D. et al. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551, 507–511 (2017).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Iwai, S. et al. Piphillin: Improved prediction of metagenomic content by direct inference from human microbiomes. PLoS One 11, e0166104 (2016).
Narayan, N. R. et al. Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences. BMC Genom. 21, 56 (2020).
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457–D462 (2016).
Conceição-Neto, N. et al. Modular approach to customise sample preparation procedures for viral metagenomics: A reproducible protocol for virome analysis. Sci. Rep. 5, 16532 (2015).
Van Espen, L. et al. A previously undescribed highly prevalent phage identified in a danish enteric virome catalog. mSystems 6, e0038221 (2021).
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, 1–10 (2009).
Nurk, S., Meleshko, D., Korobeynikov, A. & Pevzner, P. A. metaSPAdes: A new versatile metagenomic assembler. Genome Res. 27, 824–834 (2017).
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
Beller, L. et al. The virota and its transkingdom interactions in the healthy infant gut. Proc. Natl. Acad. Sci. USA 119, e2114619119 (2022).
Roux, S., Enault, F., Hurwitz, B. L. & Sullivan, M. B. VirSorter: Mining viral signal from microbial genomic data. PeerJ 3, e985 (2015).
Bin Jang, H. et al. Taxonomic assignment of uncultivated prokaryotic virus genomes is enabled by gene-sharing networks. Nat. Biotechnol. 37, 632–639 (2019).
